Key statistics dashboard for Profound Medical Corp. (PROF). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
Profound Medical Corp., through its subsidiaries, is a commercial-stage medical technology firm specializing in the development of magnetic resonance (MR)-guided ablation solutions. These innovative procedures are designed to treat conditions such as prostate disease and uterine fibroids, as well as providing palliative pain relief. The company markets its solutions across Canada, Germany, the United States, and Finland.
Stock Data
| Price | $5.86 |
| Market Cap | $213M |
| Enterprise Value | $185.0M |
| Beta | 0.47 |
| Exchange | NASDAQ |
| Country | CA |
Valuation Multiples
| P/E Ratio | -6.06 |
| Price / Book | 4.30 |
| P/S | 11.26 |
| EV/EBITDA | -5.53 |
| EV/Sales | 9.75 |
| EV/FCF | -5.17 |
| P/FCF | -5.97 |
| Earnings Yield | -15.02% |
| FCF Yield | -16.58% |
| Dividend Yield | 0.00% |
Profitability
| Gross Margin | 71.73% |
| EBIT Margin | -178.84% |
| EBITDA Margin | -176.27% |
| Operating Margin | -184.35% |
| Net Margin | -170.92% |
| Return on Equity | -62.45% |
| Return on Assets | -52.05% |
| Return on Invested Capital | -60.49% |
| Return on Capital Employed | -65.74% |
Financial Health
| Current Ratio | 6.46 |
| Quick Ratio | 5.31 |
| Cash Ratio | 4.20 |
| Debt / Equity | 0.15 |
| Debt / Assets | 11.83% |
| Net Debt / EBITDA | 0.92 |
| Interest Coverage | 0.00 |
Per-Share Data
| Revenue per share | 0.52 |
| Book Value per share | 1.37 |
| Cash per share | 1.05 |
| FCF per share | -0.98 |
| Tangible Book Value per share | 1.36 |
| Dividend per share | 0.00 |
Related companies: ARMP · AVR · CATX · LNSR · MXCT · NNOX · OWLT
Explore sector: Healthcare · Medical - Devices
More sections of PROF: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks